PRIO WEALTH LIMITED PARTNERSHIP - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.

Quarter-by-quarter ownership
PRIO WEALTH LIMITED PARTNERSHIP ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$29,882
-61.4%
23,5290.0%0.00%
-66.7%
Q2 2023$77,411
-20.0%
23,5290.0%0.00%
-25.0%
Q1 2023$96,705
-29.9%
23,5290.0%0.00%
-33.3%
Q4 2022$137,880
-13.3%
23,5290.0%0.01%
-14.3%
Q3 2022$159,056
+46.3%
23,5290.0%0.01%
+75.0%
Q2 2022$108,704
+115542.6%
23,5290.0%0.00%
+33.3%
Q1 2022$94
-99.9%
23,5290.0%0.00%
-25.0%
Q4 2021$146,000
-34.2%
23,5290.0%0.00%
-42.9%
Q3 2021$222,000
-30.6%
23,5290.0%0.01%
-36.4%
Q2 2021$320,000
-16.0%
23,5290.0%0.01%
-21.4%
Q1 2021$381,000
-39.1%
23,5290.0%0.01%
-39.1%
Q4 2020$626,000
+42.9%
23,5290.0%0.02%
+27.8%
Q3 2020$438,000
-20.5%
23,5290.0%0.02%
-28.0%
Q2 2020$551,000
+302.2%
23,5290.0%0.02%
+212.5%
Q1 2020$137,000
+1.5%
23,5290.0%0.01%
+33.3%
Q4 2019$135,000
+264.9%
23,5290.0%0.01%
+200.0%
Q3 2019$37,000
-61.1%
23,5290.0%0.00%
-50.0%
Q2 2019$95,000
-22.8%
23,5290.0%0.00%
-33.3%
Q1 2019$123,000
+29.5%
23,5290.0%0.01%
+20.0%
Q4 2018$95,000
-59.6%
23,5290.0%0.01%
-54.5%
Q3 2018$235,000
-44.0%
23,5290.0%0.01%
-47.6%
Q2 2018$420,000
+13.2%
23,5290.0%0.02%
+16.7%
Q1 2018$371,00023,5290.02%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders